ASH Young Scholar Awards

ASH members may nominate qualified young investigators for the ASH Young Scholar Award. The Young Scholar Award recognizes the achievements of outstanding young investigators in the field of hypertension.

The Young Scholar Award will be presented during the Annual Scientific Meeting and Exposition of the American Society of Hypertension, Inc.

One award will be given, with $3,000 as a personal award, and $3,000 toward laboratory expenses ($6,000 total for the award). The awardee will also be asked to give a brief lecture presenting the research for which the award was given at the ASH Annual Scientific Meeting.

To qualify for the award, candidates must have received an advance professional degree within the last 15 years and be currently active in research in hypertension or related cardiovascular diseases. Only applicants from North America are considered.

Sponsors

Who wish to have their candidates nominated for an award must be current ASH members and provide the following information:

	Complete name, address, phone, and fax numbers, and email of the nominee.
	A signed letter of recommendation from the sponsor with a description of the candidate's achievements.

 

Candidates

Should supply 8 copies of the following:

	Current curriculum vitae
	2 original publications from a scientific journal

 

For more information, please contact:
Ashley Buron, Program Coordinator
American Society of Hypertension
148 Madison Avenue, Fifth Floor
New York, NY 10016
Phone: 212.696.9099
Fax: 212.696.0711
E-mail: awards@ash-us.org

---

The 2011 Young Scholar Awards have been supported by

The American Society of Hypertension is pleased to announce the recipients of the
ASH 2011 Young Scholar Awards:

Michael J. Ryan, PhD 
Alessandro Cataliotti, MD, PhD

The 2011 Awards were presented during the ASH Twenty-Sixth Annual Scientific Meeting during the Awards Plenary Session, held on Monday, May 23rd, 2011.

Michael J. Ryan, PhD 
Dr. Ryan is an Associate Professor of Physiology & Biophysics at the University of Mississippi Medical Center in Jackson, MS.  He earned his doctorate from the State University of New York at Buffalo in 1999 and received his post-doctoral training at the University of Iowa from 1999-2004.  In 2004, he was recruited as an Assistant Professor of Physiology & Biophysics at the University of Mississippi Medical Center where he rose to his current rank of Associate Professor in 2009. 

Dr. Ryan's research focuses on the mechanistic role that chronic inflammation has in the development of hypertension.  In order to examine this link, he studies an animal model that develops the chronic autoimmune inflammatory disorder systemic lupus erythematosus (SLE).  Hypertension is prevalent and cardiovascular disease is a leading cause of death in individuals with SLE.  Dr. Ryan is specifically interested in the effect of immune and inflammatory mediators on renal function, renal injury and vascular physiology as it pertains to the development of hypertension. His work has been continuously funded by the American Heart Association and National Institutes of Health. 

Dr. Ryan currently sits on the editorial board of Hypertension, the American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, the Journal of Hypertension and Frontiers in Vascular Physiology.  He is an active member of the American Heart Association peer review system serving as a co-chair of the Vascular Biology & Blood Pressure II peer review committee.  Dr. Ryan is a Fellow of the American Heart Association and serves on the Leadership Committee of the Council for High Blood Pressure as well as on the Greater Southeast Affiliate Research Committee.  Ryan is also an active member of the American Physiological Society.  He has served on the Porter Physiology Development Committee and currently serves on the Education Committee of the American Physiological Society where he actively contributes to the educational missions of the society.

Alessandro Cataliotti, MD, PhD   
Alessandro Cataliotti, MD, PhD, is an associate consultant in the Division of Cardiovascular Diseases and Internal Medicine at Mayo Clinic Rochester. He holds the academic rank of associate professor of medicine.

Dr. Cataliotti obtained his medical degree with the highest score cum laude from the University of Catania, Italy where he also pursued residency and fellowship in internal medicine, as well as a Ph.D. program in cardiovascular science. Dr. Cataliotti began a research fellowship at Mayo Clinic under the supervision of Dr. Burnett in 1998. Throughout his research career, Dr. Cataliotti has been the recipient of numerous awards, including competitive travel awards from the American Society of Hypertension in 2000 and 2003; Heart Failure Society of America in 1999, 2000, 2001 and 2003; European Society of Hypertension in 2001; and International Society of Hypertension in 2002; and many more in the following years.  Of note, Dr. Cataliotti received a two-year grant from Bristol-Myers Squibb in 1999 in support for his research here at Mayo Clinic. Dr. Cataliotti was also a recipient of a Beginning Grant in Aid from the American Heart Association in 2003-2004.  From 2005 to 2009, he was awarded a Ministry of Education, University and Research of Italy (MIUR), Rientro dei Cervelli Project. Underscoring Dr. Cataliotti's outstanding research achievements and again recognition by his scientific peers was the awarding of one of twelve 2006 Doris Duke Clinical Scientist Development Grants. He has been funded by the National Institutes of Health and currently is the principal investigator of two RO1s.

Dr. Cataliotti's research has focused on humoral integration of the heart and kidney in heart failure and hypertension with a special emphasis upon the natriuretic peptide system. He has published over 70 publications in leading peer-reviewed journals, including the Circulation, Lancet, Proceedings of The National Academy of Science, American Journal of Physiology, Kidney International, Journal of  American Society of Nephrology, American Journal of Kidney Disease, Peptide, Journal of Hypertension, Regulatory Peptides, European Journal of Heart Failure, Hypertension, Circulation Research, American Journal of Hypertension and the Mayo Clinic Proceedings.

Dr. Cataliotti has been active in the discovery of novel drug delivery strategies for cardiac peptides in cardiovascular disease and in hypertension. He was the first to report feasibility of oral delivery of human B-type natriuretic peptide in experimental hypertension, and has pioneered the cardiac gene delivery strategy for natriuretic peptides in hypertensive heart disease.